Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status

The Multidomain Alzheimer Preventive Trial (MAPT) assessed the efficacy of omega-3 fatty acid supplementation, a multidomain intervention (MI), or a combination of both on cognition. Impact according to cerebral amyloid status was evaluated by PET scan. Read & Research Alzheimer’s More

One Comment

  1. Comment by Julie Gregory:

    Your MAPT link doesn’t work :-) Please update.

Leave a Reply